Protara Therapeutics (TARA) Shares Outstanding (2013 - 2026)

Protara Therapeutics (TARA) has 6 years of Shares Outstanding (Entity) data on file, last reported at $557631.0 in Q4 2019.

• On a quarterly basis, Shares Outstanding (Entity) rose 15.91% year-over-year to $557631.0 in Q4 2019; TTM through Dec 2019 was $557631.0, a 15.91% increase from a year earlier, with the FY2019 full-year figure at $557631.0, up 15.91% from the prior year.
• Shares Outstanding (Entity) for Q4 2019 stood at $557631.0, up from $489635.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for TARA reached as high as $557631.0 in Q4 2019 and fell as low as $411217.0 in Q1 2015.
• Historically, Shares Outstanding (Entity) has averaged $445962.2 across 5 years, with a median of $440485.0 in 2017.
• Across the five-year window, Shares Outstanding (Entity) jumped 438.47% in 2015 and rose 0.36% in 2016, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $412538.0 in 2015, then gained by 0.62% to $415089.0 in 2016, then advanced by 6.45% to $441868.0 in 2017, then grew by 8.88% to $481091.0 in 2018, then increased by 15.91% to $557631.0 in 2019.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $557631.0 in Q4 2019, $489635.0 in Q3 2019, and $489635.0 in Q2 2019.